← Leaderboards
Marina Serper
University Of Pennsylvania
$7,301,871
Attributed
$7,705,854
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,705,854 · 4
By mechanism
R01$6,744,881 · 3
K23$960,973 · 1
Top collaborators
- Therese Bittermann2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kathryn Helene Bowles$16,286,736
- Emile R. Mohler$6,792,861
- Elizabeth A Heller$8,280,996
- Barbara J Riegel$6,566,172
- Edna B Foa$22,552,226
Others in their field
Other Emerging Leaders on “Transplantation”
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$32,078,740
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Greg Westergaard · Alpha Genesis Inc$18,927,907
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$13,580,468
- Raghuveera Yaramolu · Eminent Services Corporation$9,791,923
- Kirsten Johansen · Hennepin Healthcare Research Institute$9,776,955
Research focus
TransplantationCohortCaringCirrhosisMortalityComplexUnited States National Institutes Of HealthAffectHealth SystemPrevalenceCostTransplant RecipientsHealth StatusComorbidityFutureTransplant CentersLiverLifeLiver TransplantationEnd Stage Liver DiseaseHospitalizationMedicalWaiting ListsHealthcare
Grant awards (16)
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort$685,252
R01 · FY2025 · DK · contact PI
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial$669,837
R01 · FY2025 · DK · contact PI
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$397,049
R01 · FY2025 · AA · contact PI
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort$662,784
R01 · FY2024 · DK · contact PI
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial$653,919
R01 · FY2024 · DK · contact PI
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$401,716
R01 · FY2024 · AA · contact PI
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort$699,107
R01 · FY2023 · DK · contact PI
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial$691,209
R01 · FY2023 · DK · contact PI
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$406,250
R01 · FY2023 · AA · contact PI
Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort$741,812
R01 · FY2022 · DK · contact PI
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial$735,946
R01 · FY2022 · DK · contact PI
Developing technology-based approaches to improve access and quality of care in cirrhosis$190,633
K23 · FY2022 · DK · contact PI
Developing technology-based approaches to improve access and quality of care in cirrhosis$192,097
K23 · FY2021 · DK · contact PI
Developing technology-based approaches to improve access and quality of care in cirrhosis$193,517
K23 · FY2020 · DK · contact PI
Developing technology-based approaches to improve access and quality of care in cirrhosis$194,899
K23 · FY2019 · DK · contact PI
Developing technology-based approaches to improve access and quality of care in cirrhosis$189,827
K23 · FY2018 · DK · contact PI